Kenneth G. Saag

60.5k total citations · 11 hit papers
476 papers, 26.7k citations indexed

About

Kenneth G. Saag is a scholar working on Orthopedics and Sports Medicine, Rheumatology and Surgery. According to data from OpenAlex, Kenneth G. Saag has authored 476 papers receiving a total of 26.7k indexed citations (citations by other indexed papers that have themselves been cited), including 176 papers in Orthopedics and Sports Medicine, 143 papers in Rheumatology and 121 papers in Surgery. Recurrent topics in Kenneth G. Saag's work include Bone health and osteoporosis research (168 papers), Rheumatoid Arthritis Research and Therapies (91 papers) and Gout, Hyperuricemia, Uric Acid (88 papers). Kenneth G. Saag is often cited by papers focused on Bone health and osteoporosis research (168 papers), Rheumatoid Arthritis Research and Therapies (91 papers) and Gout, Hyperuricemia, Uric Acid (88 papers). Kenneth G. Saag collaborates with scholars based in United States, Canada and United Kingdom. Kenneth G. Saag's co-authors include Jeffrey R. Curtis, Elizabeth Delzell, Ted R. Mikuls, Nicole C. Wright, Jeroan J. Allison, Bess Dawson‐Hughes, Nivedita M. Patkar, Lang Chen, James R. Cerhan and Ethel S. Siris and has published in prestigious journals such as New England Journal of Medicine, The Lancet and JAMA.

In The Last Decade

Kenneth G. Saag

463 papers receiving 25.8k citations

Hit Papers

The Recent Prevalence of ... 2004 2026 2011 2018 2014 2017 2022 2007 2018 400 800 1.2k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. The Recent Prevalence of Osteoporosis and Low Bone Mass in the United States Based on Bone Mineral Density at the Femoral Neck or Lumbar Spine
    2014 1.3k citations Nicole C. Wright, Kenneth G. Saag et al. Journal of Bone and Mineral Research profile →
  2. Romosozumab or Alendronate for Fracture Prevention in Women with Osteoporosis
    2017 942 citations Kenneth G. Saag et al. New England Journal of Medicine profile →
  3. The clinician’s guide to prevention and treatment of osteoporosis
    2022 623 citations Kenneth G. Saag et al. Osteoporosis International profile →
  4. Teriparatide or Alendronate in Glucocorticoid-Induced Osteoporosis
    2007 611 citations Kenneth G. Saag et al. New England Journal of Medicine profile →
  5. Cardiovascular Safety of Febuxostat or Allopurinol in Patients with Gout
    2018 578 citations William B. White, Kenneth G. Saag et al. New England Journal of Medicine profile →
  6. Vitamin D intake is inversely associated with rheumatoid arthritis: Results from the Iowa Women's Health Study
    2004 578 citations Jeffrey R. Curtis, Ted R. Mikuls et al. profile →
  7. Rheumatoid arthritis disease activity measures: American College of Rheumatology recommendations for use in clinical practice
    2012 553 citations Kenneth G. Saag et al. profile →
  8. 2011 American College of Rheumatology recommendations for the treatment of juvenile idiopathic arthritis: Initiation and safety monitoring of therapeutic agents for the treatment of arthritis and systemic features
    2011 549 citations Kenneth G. Saag et al. profile →
  9. American College of Rheumatology 2010 recommendations for the prevention and treatment of glucocorticoid‐induced osteoporosis
    2010 516 citations Jeffrey R. Curtis, Kenneth G. Saag et al. profile →
  10. The clinical diagnosis of osteoporosis: a position statement from the National Bone Health Alliance Working Group
    2014 438 citations John P. Bilezikian, Kenneth G. Saag et al. Osteoporosis International profile →
  11. Trends in Prevalence of Gout Among US Asian Adults, 2011-2018
    2023 60 citations Kenneth G. Saag, Hyon K. Choi et al. profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Kenneth G. Saag 8.6k 7.4k 6.0k 5.1k 4.9k 476 26.7k
Daniel H. Solomon 5.7k 0.7× 13.5k 1.8× 7.5k 1.2× 3.6k 0.7× 4.2k 0.9× 585 36.0k
Claus Christiansen 20.3k 2.4× 4.8k 0.6× 6.4k 1.1× 12.8k 2.5× 11.3k 2.3× 681 45.7k
Jeffrey R. Curtis 4.2k 0.5× 11.3k 1.5× 4.4k 0.7× 2.8k 0.6× 2.1k 0.4× 684 25.1k
Michael Doherty 3.2k 0.4× 17.6k 2.4× 11.2k 1.9× 1.2k 0.2× 3.2k 0.6× 590 33.4k
Cynthia S. Crowson 1.6k 0.2× 13.7k 1.8× 4.7k 0.8× 1.7k 0.3× 2.3k 0.5× 476 28.1k
Hang Lee 3.3k 0.4× 1.2k 0.2× 5.5k 0.9× 4.2k 0.8× 4.7k 0.9× 440 26.2k
Sherine E. Gabriel 1.2k 0.1× 16.4k 2.2× 5.3k 0.9× 1.2k 0.2× 2.2k 0.5× 202 29.3k
Matthew H. Liang 1.4k 0.2× 19.8k 2.7× 6.9k 1.1× 2.3k 0.5× 2.4k 0.5× 193 37.3k
Hyon K. Choi 1.2k 0.1× 15.6k 2.1× 9.0k 1.5× 817 0.2× 5.3k 1.1× 405 38.3k
Tore K Kvien 1.8k 0.2× 18.4k 2.5× 3.8k 0.6× 1.1k 0.2× 2.2k 0.4× 537 28.6k

Countries citing papers authored by Kenneth G. Saag

Since Specialization
Citations

This map shows the geographic impact of Kenneth G. Saag's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kenneth G. Saag with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kenneth G. Saag more than expected).

Fields of papers citing papers by Kenneth G. Saag

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kenneth G. Saag. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kenneth G. Saag. The network helps show where Kenneth G. Saag may publish in the future.

Co-authorship network of co-authors of Kenneth G. Saag

This figure shows the co-authorship network connecting the top 25 collaborators of Kenneth G. Saag. A scholar is included among the top collaborators of Kenneth G. Saag based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kenneth G. Saag. Kenneth G. Saag is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Saag, Kenneth G., Nicola Dalbeth, Chang‐Fu Kuo, et al.. (2025). Evaluation of the efficacy and safety of a novel xanthine oxidase inhibitor, tigulixostat, in gout patients with hyperuricemia: Design of the EURELIA 1 and EURELIA 2 studies. Contemporary Clinical Trials. 151. 107843–107843.
2.
Liu, Ye, Tarun Arora, Jingyi Zhang, et al.. (2025). Socioeconomic vulnerability and osteoporosis treatment disparities during COVID-19 lockdown among U.S. medicare enrollees who initiated romosozumab. Osteoporosis International. 36(12). 2555–2566.
3.
Mannion, Melissa L., Fenglong Xie, John FitzGerald, et al.. (2024). Changes in the Workforce Characteristics of Providers Who Care for Adult Patients With Rheumatologic and Musculoskeletal Disease in the United States. Arthritis & Rheumatology. 76(7). 1153–1161. 2 indexed citations
4.
Battafarano, Daniel F., et al.. (2023). “Burnout” Coupled with Workforce Shortages Spells Trouble: Innovative Solutions Are Essential for More Satisfying Rheumatology Practice. Arthritis & Rheumatology. 75(9). 1499–1502. 1 indexed citations
5.
Adami, Giovanni, Davide Gatti, Maurizio Rossini, et al.. (2023). Risk of fracture in women with glucocorticoid requiring diseases is independent from glucocorticoid use: An analysis on a nation-wide database. Bone. 179. 116958–116958. 8 indexed citations
6.
Abdellatif, Abdul, et al.. (2023). Pegloticase efficacy and safety in kidney transplant recipients; results of the phase IV, open‐label PROTECT clinical trial. Clinical Transplantation. 37(9). e14993–e14993. 5 indexed citations
7.
Qu, Haiyan, Stuart L. Silverman, Richard M. Shewchuk, et al.. (2022). Understanding Physicians’ Perceptions of Patient-Identified Barriers to Osteoporosis Medication Initiation: A Cognitive Mapping Approach. Risk Management and Healthcare Policy. Volume 15. 1293–1302.
8.
Saag, Kenneth G., T. J. de Villiers, Peter Alexandersen, et al.. (2020). Morphea-like skin lesions reported in the phase 3 Long-Term Odanacatib Fracture Trial (LOFT) in postmenopausal women with osteoporosis. Journal of the American Academy of Dermatology. 84(4). 1113–1119. 2 indexed citations
9.
Reed, Rhiannon D., Vineeta Kumar, J. Nicholas Dionne‐Odom, et al.. (2020). The Living Donor Navigator Program Provides Support Tools for Caregivers. Progress in Transplantation. 31(1). 55–61. 2 indexed citations
10.
Geusens, Piet, Bert van Rietbergen, Osvaldo Daniel Messina, et al.. (2020). Effect of Denosumab Compared With Risedronate on Bone Strength in Patients Initiating or Continuing Glucocorticoid Treatment. Journal of Bone and Mineral Research. 37(6). 1136–1146. 10 indexed citations
11.
Mikuls, Ted R., Sindhu R. Johnson, Liana Fraenkel, et al.. (2020). American College of Rheumatology Guidance for the Management of Rheumatic Disease in Adult Patients During the COVID‐19 Pandemic: Version 2. Arthritis & Rheumatology. 72(9). e1–e12. 42 indexed citations
12.
Lane, Nancy E., et al.. (2020). Real-world bone turnover marker use: impact on treatment decisions and fracture. Osteoporosis International. 32(5). 831–840. 15 indexed citations
13.
Zhang, Bo, Wei Liu, Stephenie C. Lemon, et al.. (2019). Design, analysis, power, and sample size calculation for three‐phase interrupted time series analysis in evaluation of health policy interventions. Journal of Evaluation in Clinical Practice. 26(3). 826–841. 8 indexed citations
14.
Fassio, Angelo, Giovanni Adami, Camilla Benini, et al.. (2019). Changes in Dkk-1, sclerostin, and RANKL serum levels following discontinuation of long-term denosumab treatment in postmenopausal women. Bone. 123. 191–195. 31 indexed citations
15.
Saag, Kenneth G., et al.. (2019). Is there a role for cherries in the management of gout?. Therapeutic Advances in Musculoskeletal Disease. 11. 1759720X19847018–1759720X19847018. 18 indexed citations
16.
Bone, Henry G., Felicia Cosman, Paul D. Miller, et al.. (2018). ACTIVExtend: 24 Months of Alendronate After 18 Months of Abaloparatide or Placebo for Postmenopausal Osteoporosis. The Journal of Clinical Endocrinology & Metabolism. 103(8). 2949–2957. 129 indexed citations
17.
White, William B., Kenneth G. Saag, Michael A. Becker, et al.. (2018). Cardiovascular Safety of Febuxostat or Allopurinol in Patients with Gout. New England Journal of Medicine. 378(13). 1200–1210. 578 indexed citations breakdown →
18.
Fung, Helene H., Jack Tsai, Phi Duong Nguyễn, et al.. (2016). PAIN MANAGEMENT. The Gerontologist. 56(Suppl_3). 736–736. 1 indexed citations
19.
Sambrook, Philip N., et al.. (2012). Bisphosphonates and glucocorticoid osteoporosis in men: results of a randomized controlled trial comparing zoledronic acid with risedronate. The HKU Scholars Hub (University of Hong Kong). 48 indexed citations
20.
Curtis, Jeffrey R., Andrew O. Westfall, Hong Cheng, et al.. (2008). Benefit of Adherence With Bisphosphonates Depends on Age and Fracture Type: Results From an Analysis of 101,038 New Bisphosphonate Users. Journal of Bone and Mineral Research. 23(9). 1435–1441. 95 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Daniel H. Solomon Breakdown of academic impact, for papers by Claus Christiansen Breakdown of academic impact, for papers by Jeffrey R. Curtis Breakdown of academic impact, for papers by Michael Doherty Breakdown of academic impact, for papers by Cynthia S. Crowson Breakdown of academic impact, for papers by Hang Lee Breakdown of academic impact, for papers by Sherine E. Gabriel Breakdown of academic impact, for papers by Matthew H. Liang Breakdown of academic impact, for papers by Hyon K. Choi Breakdown of academic impact, for papers by Tore K Kvien
Rankless by CCL
2026